期刊文献+

Long-term outcomes of high-risk elderly male patients with multivessel coronary disease: optimal medical therapy versus revascularization 被引量:1

Long-term outcomes of high-risk elderly male patients with multivessel coronary disease: optimal medical therapy versus revascularization
在线阅读 下载PDF
导出
摘要 Background Many studies have indicated that medical therapy and percutaneous coronary intervention have similar effects in terms of the long-term prognosis of patients with stable coronary artery disease. This study investigated the effects of optimal medical therapy (OMT) and revascularization-plus-OMT in elderly patients with high-risk angina. Methods In this prospective non-randomized study, 241 consecutive high-risk elderly male patients (65-92 years of age) with angiographically confirmed multivessel disease were enrolled in the registry from January 2004 to April 2005. Of these, 98 patients underwent OMT and 143 underwent revascularization therapy plus OMT. Results After 6.5 years of follow-up, we found that the rate of long-term cardiac mortality was significantly higher in patients who under- went OMT than in those who underwent revascularization (6.5-year unadjusted mortality rate, 14.3% for OMT vs. 7.0% for revascularization patients; log-rank P = 0.04). However, the overall risks of major adverse cardiac cerebrovascular events (MACCE) were similar among all patients (6.5-year unadjusted mortality rate, 29.6% for OMT vs. 27.3% for revascularization patients; log-rank P = 0.67). Conclusions OMT was associated with an increase in cardiac death but a similar 6.5-year risk of MACCE compared with revascularization in high-risk elderly male patients with coronary multivessel disease.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第2期152-157,共6页 老年心脏病学杂志(英文版)
基金 This study was supported by the grant from the National Natural Science Foundation of China (No. 81100160, 81470504). The authors declare no conflicts of interest.
关键词 Coronary multivessel disease High risk Optimal medical therapy REVASCULARIZATION The elderly 药物治疗 血管病变 冠状动脉 患者 老年 男性 预后 OMT
作者简介 Correspondence to: Yu-Tang WANG and Ping ZHU, MD, PhD, the First Geriatric Cardiology Division, Chinese PLA General Hospital, 28 Fuxing Rd, Beijing, China. E-mails: zhuping301@139.com. Telephone: +86-10-66876349 Fax: +86-10-66876349Correspondence to: Yu-Tang WANG and Ping ZHU, MD, PhD, the First Geriatric Cardiology Division, Chinese PLA General Hospital, 28 Fuxing Rd, Beijing, China. E-mails: wyt301@sina.com,Telephone: +86-10-66876349 Fax: +86-10-66876349
  • 相关文献

参考文献14

  • 1Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69-e171.
  • 2Kireyev D, Yun EC, Page B J, et al. Medical therapy in acute coronary syndromes: which medicines and at what doses? Curr CardiolRep 2009; 11: 267-275.
  • 3Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl JMed 2007; 356:1503-l 516.
  • 4Tanihata S, Nishigaki K, Kawasaki M, et al. Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1. Cite J2006; 70: 365-369.
  • 5Katritsis DG, Ioannidis JP. Percutaneous coronary interven- tion versus conservative therapy in nonacute coronary artery disease: a recta-analysis. Circulation 2005; 111: 2906-2912.
  • 6Allen Kt3, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in pa- tients with refractory angina. N Engl J Med 1999; 341: 1029-1036.
  • 7Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs. optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003; 289: 1117-1123.
  • 8Maron D J, Spertus JA, Mancini GB, et aL Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardio12009; 104:1055-1062.
  • 9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article. J Am Coil Cardiol 2002; 40: 1366-1374.
  • 10Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardio12007; 50:el-el57.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部